TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE… Application WO-2022232124-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2022